ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,709, issued on Aug. 25, was assigned to AIC246 AG & Co. KG (Wuppertal, Germany).

"Pharmaceutical compositions comprising 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl-3-[2-methoxy-5-(trifluoromethyl)phenyl-4H-quinazolin-4-ylacetate and sodium ions" was invented by Helmut Buschmann (Aachen, Germany), Thomas Goldner (Velbert, Germany), Jessica Redmer (Monchengladbach, Germany), Jordi Carles Ceron Bertran (La Pobla de Montornes, Spain), Andrea Hawe (Munich), Matthias Lucke (Munich), Dorothea Hohmann (Hamburg, Germany) and Monica Rosa (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to new stable pharmaceutica...